ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs)

Peer Review reports

Original Submission
25 Feb 2022	Submitted	Original manuscript
8 Apr 2022	Reviewed	Reviewer Report
14 Apr 2022	Reviewed	Reviewer Report
15 Apr 2022	Reviewed	Reviewer Report
25 Apr 2022	Author responded	Author comments - rohini sharma
Resubmission - Version 2
25 Apr 2022	Submitted	Manuscript version 2
1 Jul 2022	Author responded	Author comments - rohini sharma
Resubmission - Version 3
1 Jul 2022	Submitted	Manuscript version 3
Publishing
6 Jul 2022	Editorially accepted
20 Jul 2022	Article published	10.1186/s12885-022-09859-9

Back to article page